Explore UAB

 Website UMC Symposium Flyer 2

The 2022 Microbiome Symposium was held virtually on Monday, January 10, 2022. 

Due to the ongoing surge in COVID-19 cases, the in-person aspect of the afternoon session has been cancelled and will instead be virtual over Zoom. We look forward to featuring outstanding internationally recognized speakers who highlight the importance of microbiome-related research, its diversity, and its consequence on human health.

Keynote Speakers


Nicola Segata, Ph.D.

Nicola Segata, Ph.D.

Cellular, Computational and Integrative Biology, University of Trento, Italy

Metagenomics, machine learning, microbiome research, and microbial genomics

Haydeh Payami, Ph.D.

Haydeh Payami, Ph.D.

Neurology and Genetics, University of Alabama at Birmingham

Interaction of human genome, gut microbiome and environmental factors in causation, progression and treatment of Parkinson's disease.



January 10

 Virtual - Zoom

 9:00 – 10:00 AM  Nicola Segata PhD., Keynote Lecture: Profiling the hidden diversity of the human microbiome for biomedical applications

 10:00 – 10:3AM

 James Bibb, PhD:  Mechanistic Basis of Gastrointestinal-Neuropsychiatric Comorbidity

 10:3– 11:0AM

 Braden McFarland, PhD:  Understanding the Role of Human Microbiota in a Mouse Model of Brain Tumors

 11:00 – 11:30 AM

 Qing Zhao, PhD: Microbiota flagellin-specific antibodies in Crohn’s pathogenesis and prevention

 11:30 – 11:45 AM

Jia Li, PhD: Effects of a Low-carbohydrate/High-protein Diet on Gut Microbiome Composition in Individuals with Chronic Spinal Cord Injury

 11:30 – 12:00 PM

Natalie Lindgren: Impact of nontypeable Haemophilus influenzae on Pseudomonas aeruginosa infection in cystic fibrosis

 12:00 – 
1:00 PM

 Lunch Break

January 10 (CST)

 Virtual - Zoom

 1:00 –2:00 PM

 Haydeh Payami, PhD., Keynote LectureGut  Microbiome and Parkinson's Disease

 2:00 –2:15 PM

 Courtney Swain: Hedgehog inhibition remodels the gut microbiome in a mammary carcinoma mouse model

 2:15 – 2:45 PM

 Colin Martin, PhD: Maternal Stress and Microbial Neonatal Immunity

 2:45 – 
3:00 PM

 Callie Scull: CF Innate Immune Defect Affects CF Intestinal Microbiota

 3:00 3:20PM

 Stewart New, PhD:  Bacterial metabolism and host diet intersect to regulate selection of the innate-like B cell repertoire through mucosal immune responses

 3:20   3:40 PM

 Selene Meza-Perez, PhD:  Effects of microbiota metabolism on regulatory T cell (Treg) function in ovarian tumor metastasis

 3:4  4:00 PM

 Sadanandan Velu, PhD:  Analysis of the impact of novel biofilm inhibitors on the oral microbiome in an experimental rat model

 4:00 – 4:10 PM

 Oliva Ricks: Toll-Like Receptors Activation of Macrophages Modulates Invasion of Oral Squamous Cell Carcinoma

:20 PM

 Angela Carter, PhD: Mechanistic Insight into Microbial Regulation of Psychostimulant Abuse

:30 PM

 George Green: Metagenomic Analysis of the Gut Microbiota Community Composition, Taxonomic Co-Occurrence, and Predicted Functional Profiles in Zebrafish Danio rerio fed with a Bacterial Based Single Cell Protein Diet

:40 PM

 Laila Silamikele: Host miRNAs are associated with gut microbiome composition in high-fat-induced type 2 diabetes mouse model of both sexes

:50 PM

 Ovoke Moss: Human Microbes Influence the Efficacy of Anti-PD-1 in a Mouse Model of Melanoma

:00 PM

 Jacob Elnaggar: Shotgun metagenomic sequencing of longitudinal vaginal specimens: is Lactobacillus phage involved in the pathogenesis of bacterial vaginosis?

:10 PM

 Yuan-Tai Huang: Vancomycin-mediated gut microbiota regulation protects against chronic stress-induced anxio-depressive behavior in mice

:20 PM

 Edwin Rojas: Tetracyclic homoisoflavanoid (EMR-B) from Caesalpinia sappan inhibits Streptococcus mutans biofilms

:30 PM

 Owen Garret: Targeting Streptococcus mutans -- Candida albicans symbosis to inhibit cariogenic biofilm

 5:30 PM

 Symposium ends